CClinicalTrials.gg
Status unknownNCT05259345Updated Apr 7, 2023

Comparison of SE-TAP, M-TAPA, and Rectus Sheath Block in Abdominal Surgeries

An interventional study of Bilateral SE-TAP and Bilateral M-TAPA in Postoperative Pain, sponsored by Inonu University. Status unknown at 1 site in Turkey. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-04-07.

Sponsored by Inonu University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of this randomised controlled study is to compare the effects of three different fascial plane block [subcostal exterior semilunaris transverses abdominis plane (SE-TAP) block, modified thoracoabdominal nerves block through perichondrial approach (M-TAPA), and rectus sheath block (RSB)] on postoperative pain levels and opioid consumption in patients undergoing major abdominal surgeries with midline incision.

Read the detailed description

In last decade,ultrasound guided truncal fascial plane blocks such as transverses abdominis plane (TAP) block and rectus sheath block (RSB) have become popular as a part of postoperative multimodal analgesia for abdominal surgeries as the techniques are simple and the target sites are easily identify. Furthermore, the number of newly defined block techniques is daily increasing like M-TAPA and SE-TAP block.

The rectus sheath block (RSB) is an old technique that suite midline incisions and provides analgesia for somatic pain. The local anesthetic is injected into the space between the posterior wall of the rectus abdominis muscle and its sheath, to block the anterior branches of the thoracoabdominal nerves. It has been suggested that both anterior and lateral branches of the T5-T12 thoracoabdominal nerves are blockade in M-TAPA and SE-TAP blocks. So, they may provide better analgesia and quality of recovery for major abdominal surgeries due to presence of drains. However, the extent of the local anaesthetic diffusion and the dermatomal levels are not clear, and there is no randomised clinical trial about these new techniques, to our knowledge.

Patients and Methods: This is a prospective, randomised, double-blind clinical study; carry out on 120 patients schedule for elective major abdominal surgery with midline incision. While the fascia is closed, 1 g paracetamol and 1 mg/kg tramadol will be administered routinely to all patients for postoperative multimodal analgesia. At the end of surgery, patients will be randomly allocated into three groups (40 patients each); bilateral SE-TAP block in Group S, bilateral RSB in Group R, and bilateral M-TAPA block in Group M will be performed under ultrasound guidance. Patient controlled analgesia with intravenous morphine will be started at the recovery room. Postoperative pain levels, opioid consumption, and quality of recovery will be questioned and recorded at the first postoperative day.

02

Conditions studied

  • Postoperative Pain

Browse trials for

Keywords

  • fascial plane blocks
  • postoperative pain
  • opioid consumption
  • quality of recovery
  • abdominal surgery
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's planned enrollment of 40 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Inonu University is the lead sponsor of 375 studies on the registry; 86 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • American Society of Anesthesiology physical classification I-III
  • Scheduled for elective laparotomy with a midline incision

Exclusion criteria

Exclusion Criteria:

  • Not agree to participate in the study
  • Have mental status disorders
  • Inability to communicate
  • Known bleeding and/or coagulation disorders
  • Infection at injection site
  • Chronic opioid intake
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Group SE-TAP block

    Bilateral subcostal exterior semilunaris transverses abdominis plane (SE-TAP) block will be performed with 20 mL of local anesthetic solution (10 mL of 5% bupivacaine + 5 mL of 2% lidocaine + 5 mL of saline)

    Procedure: Bilateral SE-TAP

  • Active comparator
    Group M-TAPA block

    Bilateral modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) will be performed with 20 mL of local anesthetic solution (10 mL of 5% bupivacaine + 5 mL of 2% lidocaine + 5 mL of saline)

    Procedure: Bilateral M-TAPA

  • Active comparator
    Group RS block

    Bilateral rectus sheath block will be performed with 20 mL of local anesthetic solution (10 mL of 5% bupivacaine + 5 mL of 2% lidocaine + 5 mL of saline)

    Procedure: Bilateral RSB

Interventions

  • ProcedureBilateral SE-TAP

    A 20 mL of local anesthetic solution (10 mL of 5% bupivacaine + 5 mL of 2% lidocaine + 5 mL of saline) will be given between the internal oblique and transversus abdominis muscles toward the lateral border of the semilunar along the costal margin.

    Also known as: Ultrasound guided bilateral subcostal exterior semilunaris transversus abdomens plane block

  • ProcedureBilateral M-TAPA

    A 20 mL of local anesthetic solution (10 mL of 5% bupivacaine + 5 mL of 2% lidocaine + 5 mL of saline) will be given into the layer between the transverse abdominal muscle and the inferior plane of the costal cartilage at the midclavicular line, in the sagittal plane.

    Also known as: Ultrasound guided bilateral modified thoracoabdominal nerves block through perichondrial approach (M-TAPA)

  • ProcedureBilateral RSB

    A 20 mL of local anesthetic solution (10 mL of 5% bupivacaine + 5 mL of 2% lidocaine + 5 mL of saline) will be given between the rectus muscle and posterior rectus sheath bilaterally.

    Also known as: Ultrasound guided bilateral rectus sheath block

06

What researchers measure

Primary outcomes

  1. Quality of Recovery

    Quality of Recovery-40 (QoR-40), a 40-item questionnaire that provides a global score and subscores across five dimensions; patient support, comfort, emotions, physical independence, and pain (minimum score of 40 and maximum of 200).

    Time frame: At postoperative 24th hours

Secondary outcomes

  1. Postoperative pain

    Numeric rating scale pain from 0 (no pain) to 10 (worst pain).

    Time frame: At postoperative 48 hours (2.,6.,12.,18.,24.,48.hours)

  2. Opioid consumption

    Morphine consumption

    Time frame: At postoperative 48 hours (2.,6.,12.,18.,24.,48.hours)

07

Study locations

1 site
  • Eskisehir Osmangazi University Faculty of Medicine
    Eskisehir, 26040, Turkey
08

References and documents

Publications

  • Bakshi SG, Mapari A, Shylasree TS. REctus Sheath block for postoperative analgesia in gynecological ONcology Surgery (RESONS): a randomized-controlled trial. Can J Anaesth. 2016 Dec;63(12):1335-1344. doi: 10.1007/s12630-016-0732-9. Epub 2016 Sep 14. PubMed 27638294 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05259345
Lead sponsor
Inonu University
Responsible party
Gulay ERDOGAN KAYHAN (Professor, Inonu University) — Principal investigator
First posted
Feb 28, 2022
Start date
Feb 28, 2022
Primary completion
Feb 28, 2024 (estimated)
Completion
Mar 15, 2024 (estimated)
Last update
Apr 7, 2023

Study contacts

Gulay Erdogan Kayhan, Professor
principal investigator · Eskisehir Osmangazi University Faculty of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion